Factor | Wagner2008 (10130)

10.1128/aem.01132-07

Continuous Tylosin Use

Swine | Grower-finisher

31

Description

Tylosin was fed at 40 g/ton continuously, for the entire time the pigs were in the finishing barn (17 weeks).

Resistance Outcomes

Resistance Microbe Outcome
Tetracycline
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Continuous Tylosin Use 2 3
No Use 10 10
Tetracycline
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 98.70 150
No Use 94.80 128
Ceftiofur
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Ceftiofur
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.70 150
No Use 0.80 128
Amoxicillin And Beta-Lactamase Inhibitor
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Amoxicillin And Beta-Lactamase Inhibitor
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 2.00 150
No Use 0.00 128
Ampicillin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 33.30 3
No Use 10.00 10
Ampicillin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 30.70 150
No Use 27.30 128
Cefalotin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Cefalotin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 6.00 150
No Use 3.90 128
Cefoxitin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 1.30 150
No Use 0.00 128
Amikacin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Cefoxitin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Ciprofloxacin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Gentamicin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Nalidixic Acid
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Sulfamethoxazole And Trimethoprim
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Chloramphenicol
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 0.00 10
Kanamycin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 3
No Use 10.00 10
Streptomycin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 66.70 3
No Use 100.00 10
Sulfamethoxazole
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 66.70 3
No Use 90.00 10
Amikacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 150
No Use 0.00 128
Ceftriaxone
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 150
No Use 0.00 128
Ciprofloxacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 150
No Use 0.00 128
Nalidixic Acid
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 0.00 150
No Use 0.00 128
Chloramphenicol
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 6.00 150
No Use 10.20 128
Gentamicin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 2.00 150
No Use 6.20 128
Kanamycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 28.00 150
No Use 20.30 128
Streptomycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 25.30 150
No Use 17.20 128
Sulfamethoxazole
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 38.00 150
No Use 18.80 128
Sulfamethoxazole And Trimethoprim
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous Tylosin Use 1.30 150
No Use 0.80 128